INGN · NASDAQ
Inogen (INGN) Stock Price & Fundamentals
Inogen (INGN) closed at $507.00 on Oct 9, 2026, down 0.21% from the previous close of $508.09.
Share price, past year
1Y −8.19%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $507.00 |
| Sep 30, 2026 | $506.45 |
| Aug 31, 2026 | $536.24 |
| Jul 31, 2026 | $524.59 |
| Jun 30, 2026 | $526.62 |
| May 29, 2026 | $547.66 |
| Apr 30, 2026 | $576.98 |
| Mar 31, 2026 | $602.80 |
| Feb 27, 2026 | $565.77 |
| Jan 30, 2026 | $554.80 |
| Dec 31, 2025 | $557.37 |
| Nov 28, 2025 | $550.93 |
| Oct 31, 2025 | $571.54 |
Key statistics
- Market cap
- $13.55B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.90
- Revenue (TTM)
- $354.30M
- Net income (TTM)
- −$24.60M
- Shares outstanding
- 26.7M
- Dividend yield
- —
- 52-week range
- $502.35 – $611.73
Inogen's market cap is $13.55B, based on a share price of $507.00 and 26.7M shares outstanding as of Jun 30, 2026.
Financials
Inogen reported revenue of $348.67M for fiscal 2025, up 3.86% from fiscal 2024.
Inogen reported a net loss of $22.75M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $348.67M | +3.9% | −$22.75M | −6.5% | −$0.86 | −$13.74M |
| FY2024ended Dec 31, 2024 | $335.71M | +6.4% | −$35.89M | −10.7% | −$1.52 | $2.55M |
| FY2023ended Dec 31, 2023 | $315.66M | −16.3% | −$102.45M | −32.5% | −$4.42 | −$8.45M |
| FY2022ended Dec 31, 2022 | $377.24M | +5.4% | −$83.77M | −22.2% | −$3.67 | −$40.87M |
| FY2021ended Dec 31, 2021 | $358.00M | +16.1% | −$6.33M | −1.8% | −$0.28 | $18.15M |
| FY2020ended Dec 31, 2020 | $308.49M | −14.8% | −$5.83M | −1.9% | −$0.27 | $32.63M |
| FY2019ended Dec 31, 2019 | $361.94M | +1.1% | $20.95M | 5.8% | $0.94 | $37.45M |
| FY2018ended Dec 31, 2018 | $358.11M | +43.6% | $51.85M | 14.5% | $2.30 | $51.93M |
| FY2017ended Dec 31, 2017 | $249.44M | +23.0% | $21.00M | 8.4% | $0.96 | $57.58M |
| FY2016ended Dec 31, 2016 | $202.83M | — | $20.52M | 10.1% | $0.97 | $29.32M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $95.08M | −$3.85M | −$0.14 |
| Q1 FY2026ended Mar 31, 2026 | $85.11M | −$8.32M | −$0.30 |
| Q4 FY2025ended Dec 31, 2025 | $81.72M | −$7.13M | −$0.26 |
| Q3 FY2025ended Sep 30, 2025 | $92.39M | −$5.29M | −$0.20 |
| Q2 FY2025ended Jun 30, 2025 | $92.28M | −$4.15M | −$0.15 |
| Q1 FY2025ended Mar 31, 2025 | $82.28M | −$6.17M | −$0.25 |
| Q4 FY2024ended Dec 31, 2024 | $80.08M | −$9.76M | −$0.41 |
| Q3 FY2024ended Sep 30, 2024 | $88.83M | −$5.96M | −$0.25 |
Company profile
- Name
- Inogen Inc
- Ticker
- INGN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- 500 Cummings Center, Suite 2800, Beverly, MA 01915
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001294133
Recent SEC filings
- Sep 30, 2026
- Aug 7, 2026
- Aug 6, 2026
- Jul 1, 2026
- Jun 11, 2026
- May 8, 2026
- May 7, 2026
- Apr 6, 2026
Frequently asked questions
What is Inogen's stock price?
Inogen (INGN) closed at $507.00 on Oct 9, 2026, down 0.21% from the previous close of $508.09.
What is Inogen's market cap?
Inogen's market cap is $13.55B, based on a share price of $507.00 and 26.7M shares outstanding as of Jun 30, 2026.
How much revenue does Inogen make?
Inogen reported revenue of $348.67M for fiscal 2025, up 3.86% from fiscal 2024.
Does Inogen pay a dividend?
Inogen's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Inogen Inc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures